Stage 4: Transition to Scale
Bili-hut™ has been validated in field trials in Burundi and is currently transitioning-to-scale in Peru. Bili-hut™ has received FDA 510(k) clearance in September 2019, with expected US market entry in mid-2020 as either a home or hospital therapy.
Registered as a For-ProfitIn United States.
Maternal Newborn and Child Health, Human Centered Design and Health
Maternal Newborn and Child Health, Human Centered Design and HealthSEE LESS
Funds Raised to Date
A phototherapy device that can be used "wherever there is a baby in need" requires a design approach sensitive to underserved contexts. The ideal phototherapy device needs to be lightweight and collapsible so it can be easily transported. Using commercially available materials and low-energy consuming LED lights keeps costs low and allows for battery operation. Arranging the light array in a radial pattern on a reflective surface amplifies light delivery.
The Team Behind the Innovation
EXECUTIVE TEAM INCLUDES WOMEN